Bio-Techne (TECH) Operating Expenses (2009 - 2026)

Bio-Techne's Operating Expenses history runs 18 years deep, the most recent figure standing at $132.8 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 24.48% year-over-year to $132.8 million in Q1 2026; TTM through Mar 2026 was $632.7 million, a 1.58% increase from a year earlier, with the FY2025 full-year figure at $688.0 million, up 22.2% from the prior year.
• Operating Expenses retreated to $132.8 million in Q1 2026 per TECH's latest filing, from $136.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $222.7 million in Q2 2025 and bottomed at $110.2 million in Q2 2023.
• The 5-year median for Operating Expenses is $136.8 million (2025), against an average of $139.0 million.
• Across the five-year window, Operating Expenses soared 42.98% in 2024 and retreated 24.48% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $115.5 million in 2022, then advanced by 20.02% to $138.6 million in 2023, then grew by 5.69% to $146.5 million in 2024, then dropped by 6.59% to $136.8 million in 2025, then retreated by 2.94% to $132.8 million in 2026.
• Per Business Quant, the three latest TECH Operating Expenses figures stand at $132.8 million (Q1 2026), $136.8 million (Q4 2025), and $140.5 million (Q3 2025).